Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors
Cancers · 25.10.2024 · 16 (21) · 3603
DOI: 10.3390/cancers16213603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.10.2024. Verfasst von Jyoti Malhotra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunotherapy with PD-1/PD-L1 inhibitors is the standard method of care for the treatment of newly diagnosed advanced or metastatic NSCLC, with or without chemotherapy. Many tumors, however, develop resistance to these immunotherapy agents. There is a need to develop more effective therapies for patients with metastatic NSCLC in the second-line setting and beyond. In this review, we present an overview of novel immunotherapies being investigated regarding the treatment of these patients. We summarize completed, as well as ongoing, trials investigating these therapies as monotherapy or in combination with PD-1/PD-L1 inhibitors. These include immune co-stimulatory antibodies, T-cell agonists, oncolytic viruses, vaccines, TIL therapies, and CAR-T therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
- Department of Medicine, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
- Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.
ORCID-Profile: Jyoti Malhotra, Percy Lee
Zitieren
APA
Malhotra, J., Huang, A., Amini, A., & Lee, P. (2024). Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors. Cancers, 16(21), 3603. https://doi.org/10.3390/cancers16213603
Vancouver
Malhotra J, Huang A, Amini A, Lee P. Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors. Cancers. 2024;16(21):3603. doi:10.3390/cancers16213603
BibTeX
@article{Malhotra2024,
author = {Malhotra, Jyoti and Huang, Amy and Amini, Arya and Lee, Percy},
title = {Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors},
journal = {Cancers},
year = {2024},
volume = {16},
number = {21},
pages = {3603},
doi = {10.3390/cancers16213603}
}
EUVIMED